TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05223803: TERPS Trial for de Novo Oligometastic Prostate Cancer

Sponsor: University of Maryland, Baltimore · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 122 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$554,400

Rescue Site Savings

+$369,600

Unlock Full NCT05223803 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05223803 Rescue Dossier →